In a comparison of four caspase inhibitors, the baculovirus protein p35, a 35-kDa single chain broad-spectrum caspase inhibitor [27,28], was found to be the most effective in delaying the death of CPA-treated 9L gliosarcoma cells stably expressing P450 [29]. Here, CYP2B6 is linked to gliosarcoma.